Entrada Therapeutics started at outperform with $22 stock price target at Oppenheimer
Post Content
BioNTech started at perform at Oppenheimer
Post Content
Synovus Financial upgraded to strong buy from outperform at Raymond James
Post Content
Dun & Bradstreet upgraded to strong buy from outperform at Raymond James
Post Content
Old Second Bancorp downgraded to outperform from strong buy at Raymond James
Post Content
Texas Capital Bancshares downgraded to outperform from strong buy at Raymond James
Post Content
Business First Bancshares downgraded to market perform from outperform at Raymond James
Post Content
SouthState downgraded to market perform from outperform at Raymond James
Post Content
Ally Financial downgraded to underperform from market perform at Raymond James
Post Content
WesBanco upgraded to outperform from market perform at Raymond James
Post Content